| request information: |
|
| Catalog Code: | NB120-11216 |
| Product Name: | Cytokeratin 13 Antibody |
| Product Description: | Mouse Polyclonal anti-Cytokeratin 13 (KS-1A3) |
| Clone: | KS-1A3 |
| Clonality: | Polyclonal |
| ListPrice: | 295 |
| Immunogen: | cultured human epidermoid carcinoma cell line A-431. |
| Specificity: | The antibody reacts with squamous, non-keratinized epithelium, transitional epithelium, pseudostratified epithelium, and myoepithelium. |
| Cross Reactivity: | Cross-reacts with Human.Not yet tested in other species. |
| Packaging: | 0.1 ml purified Mouse antisera. |
| Uses: | IF: Use at a dilution of 1/100. Not tested in other applications.Optimal dilutions/concentrations should be determined by the end user. |
| Localization: | Cytoplasmic |
| Background: | Cytokeratin 13 is a member of the keratin gene family. The keratins are intermediate filament proteins responsible for the structural integrity of epithelial cells and are subdivided into cytokeratins and hair keratins. Most of the type I cytokeratins consist of acidic proteins which are arranged in pairs of heterotypic keratin chains. This type I cytokeratin is paired with keratin 4 and expressed in the suprabasal layers of non-cornified stratified epithelia. Mutations in this gene and keratin 4 have been associated with the autosomal dominant disorder White Sponge Nevus. |
| Purity: | Ascites |
| Isotype: | IgG1 |
| Host Name: | Mouse |
| Buffer: | Preservative: 0.1% Sodium Azide Constituents: Whole Serum |
| Application Summary: | immunofluorescence |
| Species Summary: | Hu |
| Alternate Names: | anti-CK 13 antibody, anti-CK13 antibody, anti-Cytokeratin13 antibody, anti-K13 antibody, anti-Keratin 13 antibody, anti-keratin type I cytoskeletal 13 antibody, anti-Keratin13 antibody, anti-KRT 13 antibody, anti-KRT13 antibody, anti-MGC3781 antibody |
| Package Size: | 0.1 ml |
| General References: | Store at 4°C short term (1-2 weeks). Aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles. |
| Novus References: | 1. Macias E, Kim Y, Miliani de Marval PL, Klein-Szanto A, Rodriguez-Puebla ML. Cdk2 Deficiency Decreases ras/CDK4-Dependent Malignant Progression, but Not myc-Induced Tumorigenesis. Cancer Res. 2007 October 15, 2007;67(20):9713-20. |
order or
more information: | company product webpage |